Scientists and activists convened at a massive conference in Denver last week to declare a renaissance for drugs like psilocybin and MDMA. But whose vision will prevail?

“Welcome to the psychedelic twenties.”
This is how Rick Doblin, founder and president of the Multidisciplinary Association for Psychedelic Studies (MAPS), greeted a packed crowd on the opening morni…